$114M sweet spot round size
Most of their 31 investments are in rounds between $60M and $175M
1997
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners, Omega Funds and Marshall Wace
AN2 Therapeutics raised $70M on August 15, 2023
Investors: TCG X, Avidity Partners, Adage Capital Management, RA Capital Management, L.P., Surveyor Capital and Marshall Wace
InspireMD raised $114M on May 15, 2023
Investors: Velan Capital, LifeSci Capital, LLC, OrbiMed Advisors, Soleus Capital Management, L.P. and Marshall Wace
Prognos Health raised $23M on May 4, 2023
Investors: Red & Blue Ventures, Hikma Ventures, Labcorp, MAYWIC Select Investments, Safeguard Scientifics and Marshall Wace
Karyopharm Therapeutics Inc. raised $165M on December 5, 2022
Investors: Adage Capital Management, HEALTHCOR LTD, Armistice Capital LLC, Surveyor Capital, Avidity Partners and Marshall Wace
TRM Labs raised $70M on November 9, 2022
Investors: Pario Ventures, Thoma Bravo, CMT Digital, DRW Venture Capital, Geodesic Capital and Marshall Wace
VectivBio AG raised $125M on October 13, 2022
Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Vivo Capital, Driehaus Capital Management LLC, Forbion and Marshall Wace
Undisclosed raised $68M on September 12, 2022
Investors: Bluestem Capital Co, MVM Partners and Marshall Wace
Elektrofi raised $40M on June 13, 2022
Investors: Logos Global Management, LP and Marshall Wace
Turtlemint raised $120M on April 29, 2022
Investors: Amansa Capital Pte. Ltd., Nexus Venture Partners, Vitruvian Partners, Jungle Ventures and Marshall Wace